![]() |
CRDF | Cardiff Oncology, Inc. |
Biological Products (no Diagnostic Substances) |
Book value per $ invested | $ 0.50 |
Leverage | 22.62% |
Market Cap | $ 117.9m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -50.9m |
Margin | -9212.87% |
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.